SCHEMBL124950

SCHEMBL124950

CCCOc1ccccc1C(=O)O

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.71
KMT2A Q03164 4/20 0.71
PTK2B Q14289 1/20 0.71
KDM4E B2RXH2 6/20 0.59
HTT P42858 2/20 0.59
MEN1 O00255 3/20 0.58
HIF1A Q16665 1/20 0.58
LMNA P02545 3/20 0.57
RECQL P46063 1/20 0.57
NR1I2 O75469 1/20 0.57
CHRM2 P08172 1/20 0.57
CYP3A4 P08684 1/20 0.57
ADRA2A P08913 1/20 0.57
MAPT P10636 1/20 0.57
OPRK1 P41145 1/20 0.57
HTR2B P41595 1/20 0.57
SLC6A3 Q01959 1/20 0.57
HDAC6 Q9UBN7 1/20 0.57
HPGD P15428 2/20 0.55
HSD17B10 Q99714 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31643582 1.00 ALDH1A1 (0.71) ALDH1A1KMT2APTK2BKDM4EHTT
SCHEMBL28219872 0.98 ALDH1A1 (0.69) ALDH1A1KMT2APTK2BKDM4EHTT
Bicarbonate SCHEMBL21753663 0.98 ALDH1A1 (0.69) ALDH1A1KMT2APTK2BKDM4EHTT
Bicarbonate SCHEMBL236595 0.98 ALDH1A1 (0.69) ALDH1A1KMT2APTK2BKDM4EHTT
Bicarbonate SCHEMBL29943695 0.98 ALDH1A1 (0.69) ALDH1A1KMT2APTK2BKDM4EHTT
Fumaric Acid SCHEMBL28890188 0.92 ALDH1A1 (0.61) ALDH1A1KMT2APTK2BKDM4EHTT
SCHEMBL301123 0.91 KMT2A (0.69) ALDH1A1KMT2APTK2BKDM4EHTT
SCHEMBL29994009 0.91 KMT2A (0.69) ALDH1A1KMT2APTK2BKDM4EHTT
Benzene SCHEMBL28006345 0.91 KMT2A (0.69) ALDH1A1KMT2APTK2BKDM4EHTT
SCHEMBL1727339 0.91 ALDH1A1 (0.59) ALDH1A1KMT2APTK2BKDM4EHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1405 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12551542-B2 Polymeric nanoparticles that target liver sinusoidal endothelial cells to induce antigen-specific immune tolerance THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2026-02-17 US claimed
US-20250268816-A1 EXTENDED-RELEASE FORMULATION CONTAINING CRESOL UNIVERSITY OF MARYLAND, BALTIMORE 2025-08-28 US claimed
EP-4514322-A1 EXTENDED-RELEASE FORMULATION CONTAINING CRESOL University of Maryland, Baltimore (US) 2025-03-05 EP claimed
US-20250025605-A1 TISSUE SCAFFOLD MATERIALS FOR TISSUE REGENERATION AND METHODS OF MAKING CORNELL UNIVERSITY (US) 2025-01-23 US claimed
US-20240309177-A1 PLASTICIZER COMPOSITION FOR VINYL CHLORIDE RESIN, PLASTISOL, AND COATING FILM THEREOF DIC CORPORATION (JP) 2024-09-19 US claimed
CN-118184679-A Photothermal agent and preparation method thereof, photothermal nanoparticle and preparation method thereof, insulating material and self-repairing method of insulating material 中国石油天然气股份有限公司 2024-06-14 CN claimed
EP-4373521-A2 SINGLE- AND MULTI-EPITOPE PEPTIDE AND MRNA VACCINES TO GENERATE TOLEROGENIC EFFECTS FOR ALLERGIC AN AUTOIMMUNE DISEASE The Regents of University of California (US) 2024-05-29 EP claimed
EP-4368669-A1 PLASTICIZER COMPOSITION FOR VINYL CHLORIDE RESIN, PLASTISOL AND COATING THEREOF DIC Corporation (JP) 2024-05-15 EP claimed
WO-2023212033-A9 EXTENDED-RELEASE FORMULATION CONTAINING CRESOL UNIVERSITY OF MARYLAND, BALTIMORE (US) 2024-03-28 WO claimed
CN-117460780-A Plasticizer composition for vinyl chloride resin, plastisol and coating film thereof DIC株式会社 2024-01-26 CN claimed
US-20020058057-A1 Brachytherapy seed MICROSPHERIX LLC 2002-05-16 US claimed
JP-3126141-B2 2001-01-22 JP claimed
EP-1027886-A2 Pharmaceutical solid dispersions Pfizer Products Inc. (US) 2000-08-16 EP claimed
EP-0990047-A2 METHODS AND COMPOSITIONS FOR ANALYZING NUCLEIC ACID MOLECULES UTILIZING SIZING TECHNIQUES Rapigene, Inc. (US) 2000-04-05 EP claimed
WO-1999005319-A9 METHODS AND COMPOUNDS FOR ANALYZING NUCLEIC ACIDS BY MASS SPECTROMETRY RAPIGENE INC (US) 1999-06-17 WO claimed
WO-1999005319-A2 METHODS AND COMPOUNDS FOR ANALYZING NUCLEIC ACIDS BY MASS SPECTROMETRY RAPIGENE, INC. (US) 1999-02-04 WO claimed
EP-0550615-B1 DRUG DELIVERY VEHICLES SUSPENDED IN NONAQUEOUS PERFLUORINATED CARRIER ALLERGAN INC (US) 1995-08-02 EP claimed
EP-0511292-A1 POLYANHYDRIDES OF THE OLIGOMERIZED UNSATURATED ALIPHATIC ACIDS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 1992-11-04 EP claimed
EP-0268214-B1 PROCESS FOR PRODUCING PROPYLENE OLIGOMERS IDEMITSU KOSAN COMPANY LIMITED (JP) 1991-08-21 EP claimed
WO-1991010696-A1 POLYANHYDRIDES OF THE OLIGOMERIZED UNSATURATED ALIPHATIC ACIDS NOVA PHARMACEUTICAL CORPORATION (US) 1991-07-25 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12551542-B2 Polymeric nanoparticles that target liver sinusoidal endothelial cells to induce antigen-specific immune tolerance HAVCR2, CD74, CD44 ALDH1A1 1251/4885KMT2A 3872/4885PTK2B 1283/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.